5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid
C18H20F4N6O3 — CID 175921425
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid
5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid (PubChem CID 175921425) has the molecular formula C18H20F4N6O3 and a molecular weight of 444.39 g/mol. Its IUPAC name is 5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 175921425 |
| Molecular Formula | C18H20F4N6O3 |
| Molecular Weight | 444.39 g/mol |
| Exact Mass | 444.15 |
| IUPAC Name | 5-N-[1-[2-(2-aminoethoxy)-5-fluorophenyl]ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine;2,2,2-trifluoroacetic acid |
| SMILES | CC(Nc1ccn2ncc(N)c2n1)c1cc(F)ccc1OCCN.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C16H19FN6O.C2HF3O2/c1-10(12-8-11(17)2-3-14(12)24-7-5-18)21-15-4-6-23-16(22-15)13(19)9-20-23;3-2(4,5)1(6)7/h2-4,6,8-10H,5,7,18-19H2,1H3,(H,21,22);(H,6,7) |
| InChIKey | NCIBSNMUIOIJKY-UHFFFAOYSA-N |
| XLogP | 2.59 |
| TPSA | 140.79 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 444.39 |
| LogP ≤ 5 | 2.59 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175921425 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.